Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-20-062720

General Counsel and Secretary acquired 22,026 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KASINGER JAMES R. General Counsel and Secretary 2020-12-09 Option exercise +22,026 $13.62 $299,994 22,415 D
Derivatives
KASINGER JAMES R. General Counsel and Secretary 2020-12-09 Option exercise · Stock Option (right to buy) −22,026 100,974 D
Loading xslF345X03/doc4.xml…